| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/04/2003 | US6514729 Recombinant interferon-beta muteins |
| 02/04/2003 | US6514727 Isolated nucleic acid molecule encoding a cyclic peptide having amino acids linked by peptide bonds and interchain crosslinks. |
| 02/04/2003 | US6514724 Isolated polynucleotide encoding a polypeptide which has high binding affinity. |
| 02/04/2003 | US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 02/04/2003 | US6514707 Methods for detection of prion protein as an indication of transmissible spongiform encephalophathies |
| 02/04/2003 | US6514696 Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer |
| 02/04/2003 | US6514690 Immunoreactive antigens of Hepatitis E Virus |
| 02/04/2003 | US6514497 Inhibition of LERK-2-mediated cell adhesion |
| 02/04/2003 | CA2171953C Modified truncated complement system regulators |
| 02/04/2003 | CA2109815C Antibody preparation |
| 02/04/2003 | CA2063810C Production of vascular endothelial cell growth factor |
| 02/04/2003 | CA2060325C Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides |
| 02/03/2003 | WO2002016548A2 Novel g protein-coupled receptor |
| 02/03/2003 | CA2418130A1 Novel g protein-coupled receptor |
| 01/31/2003 | WO2002012338A2 Screening method |
| 01/31/2003 | CA2417972A1 Screening method |
| 01/30/2003 | WO2003008620A1 Chemical eraction circuit for cell-free protein synthesis |
| 01/30/2003 | WO2003008581A1 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING APOPTOSIS REGULATOR |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008575A2 Dna sequences for regulating transcription |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008560A2 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008541A2 Extracellular junctional adhesion molecules |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 01/30/2003 | WO2003008451A2 Modification of human variable domains |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008441A2 Moringa seed proteins |
| 01/30/2003 | WO2003008376A2 Adhesive dopa-containing polymers and related methods of use |
| 01/30/2003 | WO2003007989A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007890A2 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007886A2 Plant ion channels and methods |
| 01/30/2003 | WO2003007881A2 Antibodies specific for nanotubes and related methods and compositions |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007685A2 Detecting and treating reproductive tract disorders |
| 01/30/2003 | WO2002050257A3 Method for the production of polyfructans |
| 01/30/2003 | WO2002048382A3 Method for the production of a heterologous protein by a fungus |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002004599A3 Placental protein having multiple egf-like domains |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023074 Galanin receptor GALR3 and nucleotides encoding same |
| 01/30/2003 | US20030023071 DNA encoding proteins that inhibit Hsp70 function |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |
| 01/30/2003 | US20030023067 Follistatin-related protein zfsta2 |
| 01/30/2003 | US20030023061 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 01/30/2003 | US20030023056 In immunogenic preparations or diagnostic applications |
| 01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030023047 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer |
| 01/30/2003 | US20030023045 Reshaped human antibody to human medulloblastoma cells |
| 01/30/2003 | US20030023044 Human G-Protein chemokine receptor (CCR5) HDGNR10 |
| 01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
| 01/30/2003 | US20030022859 Method for increasing the gene expression of transfected genes |
| 01/30/2003 | US20030022855 Melanoma differentiation associated gene-5 (mda-5) nucleic acids, proteins, and gene promoters for induction of apoptotic cell death |
| 01/30/2003 | US20030022822 Novel compounds |
| 01/30/2003 | US20030022349 Virulence-associated nucleic acid sequences and uses thereof |
| 01/30/2003 | US20030022338 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022315 Expression of preferential gene in cells; obtain cell, incubate with vector, transform cells, express vector, monitor gene expression inhibition |
| 01/30/2003 | US20030022314 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent |
| 01/30/2003 | US20030022312 Human hepatoma-derived growth factor-2 |
| 01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 01/30/2003 | US20030022305 Nucleotide sequences coding polypeptide for use in the detection of modulators and herbicides |
| 01/30/2003 | US20030022291 Production of a multimeric protein by cell fusion method |
| 01/30/2003 | US20030022288 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/30/2003 | US20030022287 Non aggregating fluorescent proteins and methods for using the same |
| 01/30/2003 | US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects |
| 01/30/2003 | US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 01/30/2003 | US20030022277 Nucleotide sequences coding polypeptide or use in the treatment of eating disorders |
| 01/30/2003 | US20030022275 Human nk-3 related prostate specific gene-1 |
| 01/30/2003 | US20030022262 Methods of detecting early renal disease in animals |
| 01/30/2003 | US20030022244 Single chain antibody against mutant P53 |
| 01/30/2003 | US20030022238 Methods of identifying agents which inhibit GPR-9-6 |
| 01/30/2003 | US20030022236 Generation of preferental protein libraries; obtain nucleotide sequences, translate in vitro, recover protein product |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030021795 Administering antibody; determination binding to peptide |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021781 Administering antibodies |
| 01/30/2003 | US20030021779 Immunology response; monoclonal antibodies |
| 01/30/2003 | US20030021778 Ocular treatment by topical application of an immunoglobulin |
| 01/30/2003 | CA2454490A1 Chemical reaction circuit for cell-free protein synthesis |
| 01/30/2003 | CA2454427A1 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | CA2454226A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453662A1 Modification of human variable domains |
| 01/30/2003 | CA2453428A1 Plant ion channels and methods |
| 01/30/2003 | CA2452518A1 Inhibition of behab cleavage and primary central nervous system (cns) tumors |